A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001) (clinicaltrials.gov) - Oct 14, 2026 - P1 | N=80 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
Monotherapy • New P1 trial • Platinum resistant • Platinum sensitive • Endometrial Cancer • Oncology • Ovarian Cancer • Solid Tumor
|